Cramer has his eye on several names that are scheduled to report before the opening bell Thursday.
When Avon Products announces earnings, the "Mad Money" host wants to hear either a better quarter or that there's a change in leadership.
Two important drug companies also report ahead of the open. Cramer thinks Bristol-Myers Squibb will have good news about new products, and expects Celgene to raise guidance, as well as talk about the extension of their Revlimid franchise to treat different kinds of cancer.
Also before the open, we’ll hear from Exxon Mobil . Cramer hopes the oil and gas giant talks about the coming natural gas boom. Otherwise, he thinks it will deliver another boring quarter.
And he's expecting positive news when two paid-to-wait names report their quarterly earnings. He's betting International Paper will be "great" and Waste Management will be "better than expected."
Finally, Procter & Gamble also announces its earnings before the open. With Pringles being sold, its worldwide initiatives in place and raw costs down, Cramer wonders if this may be the break out quarter we’ve been waiting for.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the Mad Money website? email@example.com